BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26921839)

  • 1. Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective.
    Sleeboom-Faulkner M; Chekar CK; Faulkner A; Heitmeyer C; Marouda M; Rosemann A; Chaisinthop N; Chang HC; Ely A; Kato M; Patra PK; Su Y; Sui S; Suzuki W; Zhang X
    Soc Sci Med; 2016 Mar; 153():240-9. PubMed ID: 26921839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better safe than sorry: ethics review in European Union-funded health research.
    Draghia-Akli R; Hoeveler A; Löffler P; Namorado J
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():47-50. PubMed ID: 25457962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An appraisal of human experimentation in international law and practice: the need for international regulation of human experimentation.
    Bassiouni MC; Baffes TG; Evrard JT
    J Crim Law Criminol; 1981; 72(4):1597-666. PubMed ID: 11649443
    [No Abstract]   [Full Text] [Related]  

  • 4. Global challenges in stem cell research and the many roads ahead.
    Sipp D
    Neuron; 2011 May; 70(4):573-6. PubMed ID: 21609815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The international translational regenerative medicine center.
    Alexis Mde V; Grinnemo KH; Jove R
    Regen Med; 2012 Nov; 7(6 Suppl):74-5. PubMed ID: 23210815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of recombinant DNA research: a comparative study.
    Teichmann DL
    Loyola Los Angel Int Comp Law J; 1983; 6(1):1-35. PubMed ID: 15739273
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization as situation-specific achievement: regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine.
    Rosemann A
    Soc Sci Med; 2014 Dec; 122():72-80. PubMed ID: 25441319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations.
    Rosemann A; Bortz G; Vasen F; Sleeboom-Faulkner M
    Regen Med; 2016 Oct; 11(7):647-57. PubMed ID: 27622527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oversight for clinical uses of autologous adult stem cells: lessons from international regulations.
    Lysaght T; Kerridge I; Sipp D; Porter G; Capps BJ
    Cell Stem Cell; 2013 Dec; 13(6):647-51. PubMed ID: 24315438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Convergence of healthcare regulation in the Americas: history, development, and new challenges].
    Silva AP; Tagliari PO
    Rev Panam Salud Publica; 2016 May; 39(5):281-287. PubMed ID: 27706413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New York State's landmark policies on oversight and compensation for egg donation to stem cell research.
    Roxland BE
    Regen Med; 2012 May; 7(3):397-408. PubMed ID: 22458727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflection on the governance of clinical stem cell research and applications in China.
    Chen H
    Regen Med; 2017 Sep; 12(6):593-597. PubMed ID: 28976281
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cell policy in the Obama age: UK and US perspectives.
    Matthews KR; Rowland ML
    Regen Med; 2011 Jan; 6(1):125-32. PubMed ID: 21175292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
    Baark E; Jamison A
    Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in the geographic distribution of human embryonic stem-cell research.
    Levine A
    Politics Life Sci; 2004 Sep; 23(2):40-5. PubMed ID: 16859385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Law, ethics, religion, and clinical translation in the 21st century--a conversation with Anthony D. Ho. Interview by Majlinda Lako, Alan O. Trounson, and Susan Daher.
    Ho AD
    Stem Cells; 2011 Mar; 29(3):387-8. PubMed ID: 21425401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.